← FDA Drug Approvals (Drugs@FDA)

CIBINQO

NDA · New Drug Application · Sponsor: PFIZER · Approved 2022-01-14

Drug application

FDA Application #

NDA213871

Application type

New Drug Application

Brand name

CIBINQO

Generic name

ABROCITINIB

Active ingredients

ABROCITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

U.S. Pharmaceuticals

First approval

2022-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown